0001209191-18-032407.txt : 20180522
0001209191-18-032407.hdr.sgml : 20180522
20180522180408
ACCESSION NUMBER: 0001209191-18-032407
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180521
FILED AS OF DATE: 20180522
DATE AS OF CHANGE: 20180522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cagle Gerald D.
CENTRAL INDEX KEY: 0001589991
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36152
FILM NUMBER: 18853484
MAIL ADDRESS:
STREET 1: 135 U.S. HIGHWAY 206
STREET 2: SUITE 15
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001337553
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203109565
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7020 KIT CREEK ROAD
STREET 2: SUITE 270
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: 919-313-9650
MAIL ADDRESS:
STREET 1: 7020 KIT CREEK ROAD
STREET 2: SUITE 270
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-05-21
0
0001337553
AERIE PHARMACEUTICALS INC
AERI
0001589991
Cagle Gerald D.
C/O AERIE PHARMACEUTICALS, INC.
4301 EMPEROR BLVD., SUITE 400
DURHAM
NC
27703
1
0
0
0
Common Stock
2018-05-21
4
P
0
1000
50.245
A
15050
D
/s/ Richard J. Rubino, Attorney-in-Fact for Gerald D. Cagle
2018-05-22